Our prior studies show in vitro-generated CD103+ cDC1s possess key features of the nonlymphoid organ cDC1 subset found in vivo, and serve as an effective tumor vaccine in murine melanoma and osteosarcoma [20]. This evidence concerns the gene MPPE1 and osteosarcoma.